Skip to main content
Data in Brief logoLink to Data in Brief
. 2015 Oct 1;5:379–382. doi: 10.1016/j.dib.2015.09.024

Data on in vitro and in vivo cell orientation on substrates with different topographies

Andrew English a,b,c, Ayesha Azeem a,b,c, Kyriakos Spanoudes a,b,c, Eleanor Jones d, Bhawana Tripathi e, Nandita Basu e, Karrina McNamara f, Syed AM Tofail f, Niall Rooney g, Graham Riley d, Alan O׳Riordan h, Graham Cross e, Dietmar Hutmacher i, Manus Biggs b,c, Abhay Pandit b,c, Dimitrios I Zeugolis a,b,c,
PMCID: PMC4781899  PMID: 26977425

Abstract

This data article contains data related to the research article entitled “Substrate topography: A valuable in vitro tool, but a clinical red herring for in vivo tenogenesis” [1]. We report measurements on tenocyte viability, metabolic activity and proliferation on substrates with different topographies. We also report the effect of substrates with different topographies on host cells in a subcutaneous model.

Keywords: Imprinting, Anisotropic substrates, Tenocytes, Subcutaneous model


Specifications table

Subject area
Biology
More specific subject area Biomaterials/Tissue Engineering
Type of data Figures
How data was acquired in vitro assays; in vivo assays
Data format Analysed data
Experimental factors Substrates with various topographies
Experimental features in vitro and in vivo data
Data source location Galway, Ireland
Data accessibility Data are supplied in this article

Value of the data:

  • Two-dimensional substrates, with appropriate topographical features and rigidity, may be used to maintain cell phenotype ex vivo.

  • Two-dimensional substrates, with sub-micron to low micron features, may not be suitable for directional neotissue formation in vivo.

  • Three-dimensional constructs may be more effective tools for directional neotissue formation in vivo.

1. Data

Herein, we assessed tenocyte viability, metabolic activity and proliferation on substrates with different topographies. The substrates were poly(lactic-co-glycolic acid) (PLGA) based with constant groove and line width of 1911.42±37.50 nm and 2101.78±35.21 nm respectively and variable groove depth of 37.48±3.4 nm, 317.29±7.05 nm and 1988.2±195.3 nm. Non-imprinted substrates were used as control. We also assessed these these substrates in a subcutaneous model.

2. Experimental design, materials and methods

2.1. Human tenocyte viability, metabolic activity and proliferation

Live/Dead® assay (BioSource International, Invitrogen, Ireland) was performed on days 1, 5 and 10 to assess cellular viability, as per manufacturer׳s protocol. Briefly, cells were washed 3 times with HBSS and exposed to the staining solution of calcein and ethidium homodimer. The cells were incubated at 37 °C for 45 min. Following staining, the cells were viewed using the BX51 Olympus fluorescence microscope and analysed using ImageJ.

Cell metabolic activity was determined using alamarBlue® assay on days 1, 5, and 10, as per manufacturer׳s protocol. Briefly, alamarBlue® dye was diluted with HBSS to make a 10% (v/v) alamarBlue® solution. Media was removed from each well and 0.5 ml alamarBlue® solution was added to each well. Cell were incubated for 3 h at 37 °C; the absorbance of the alamarBlue® was measured at wavelengths of 550 nm and 595 nm using a microplate reader (Varioskan Flash, Thermo Scientific, UK). The level of metabolic activity was calculated using the simplified method of calculating % reduction, according to the supplier’s protocol.

Cell proliferation was assessed on days 1, 5, and 10, by counting DAPI stained cell nuclei, using the BX51 Olympus fluorescence microscope.

All experiments (viability, metabolic activity and proliferation) were repeated in three independent experiments and each experiment was performed in triplicate.

2.2. in vivo study and analysis

The Animal Care Research Ethics Committee of NUI Galway approved all experimental protocols. For the subcutaneous study, female Lewis rats (200–250 g) were used, following a protocol described previously [2]. Briefly, surgery was performed on rats under general anaesthesia. Incisions were made at the back of each animal, allowing insertion of a 0.5 cm×0.5 cm structured substrate. The wound was then closed, using biodegradable sutures. Following euthanisation, the substrates were harvested at days 2 and 14 and were stained using DAPI and rhodamine conjugated phalloidin. Three animals were used per time point and at each animal all three structured substrates were implanted. Images were captured with an Olympus IX-81 inverted microscope (Olympus Corporation, Tokyo, Japan).

3. Results

Fig. 1, Fig. 2.

Fig. 1.

Fig. 1

Tenocyte viability, metabolic activity and proliferation as a function of substrate topography and time in culture. No significant differences were detected.

Fig. 2.

Fig. 2

Microscopic images of host cells on substrates with different topographies. Nuclei were stained blue with DAPI and cytoskeleton was stained red with rhodamine-conjugated phalloidin. Substrate topography did not affect host cell orientation.

Acknowledgements

This work was supported by: Enterprise Ireland, Collaborative Centre for Applied Nanotechnology (Project no: CCIRP-2007-CCAN-0509), under the Irish Government’s National Development Plan 2007-2013 to DZ; Tyndall National Institute, SFI-funded National Access Programme (Project no: NAP382) to DZ; Health Research Board (Project no: HRA_POR/2011/84) to DZ; Irish Research Council, Government of Ireland Postgraduate Scholarship Scheme (Grant agreement no.: GOIPG/2014/385) to KS and DZ. MB is a Science Foundation Ireland, Starting Investigator SIRG COFUND fellow (Project no: 11/SIRG/B2135). The authors would also like to acknowledge Ms. B. Hasegawa for technical support.

Footnotes

Appendix A

Supplementary data associated with this article can be found in the online version at 10.1016/j.dib.2015.09.024.

Appendix A. Supplementary material

Supplementary material

mmc1.pdf (1.2MB, pdf)

References

  • 1.English A., Azeem A., Spanoudes K., Jones E., Tripathi B., BasuN N., McNamara K., Tofail S.A.M, Rooney N., Riley G., O׳Riordan A., Cross G., Hutmacher D., Biggs M., Pandit A., Zeugolis D.I. Substrate topography: a valuable in vitro tool, but a clinical red herring for in vivo tenogenesis. Acta Biomater. 2015 doi: 10.1016/j.actbio.2015.08.035. (submitted for publication) [DOI] [PubMed] [Google Scholar]
  • 2.Keeney M., van den Beucken J., van der Kraan P., Jansen J., Pandit A. The ability of a collagen/calcium phosphate scaffold to act as its own vector for gene delivery and to promote bone formation via transfection with VEGF(165) Biomaterials. 2010;31:2893–2902. doi: 10.1016/j.biomaterials.2009.12.041. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary material

mmc1.pdf (1.2MB, pdf)

Articles from Data in Brief are provided here courtesy of Elsevier

RESOURCES